Pharmacological effects and mechanisms of bee venom and its main components: Recent progress and perspective
P Shi, S Xie, J Yang, Y Zhang, S Han, S Su… - Frontiers in …, 2022 - frontiersin.org
Bee venom (BV), a type of defensive venom, has been confirmed to have favorable
activities, such as anti-tumor, neuroprotective, anti-inflammatory, analgesic, anti-infectivity …
activities, such as anti-tumor, neuroprotective, anti-inflammatory, analgesic, anti-infectivity …
Precision medicine in hymenoptera venom allergy: diagnostics, biomarkers, and therapy of different endotypes and phenotypes
Allergic reactions to stings of Hymenoptera species may be severe and are potentially fatal
deviations of the immunological response observed in healthy individuals. However, venom …
deviations of the immunological response observed in healthy individuals. However, venom …
Bee venom—a potential complementary medicine candidate for SARS-CoV-2 infections
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by severe
cytokine storm syndrome following inflammation. SARS-CoV-2 directly interacts with …
cytokine storm syndrome following inflammation. SARS-CoV-2 directly interacts with …
Risk factors for systemic reactions in typical cold urticaria: results from the COLD‐CE study
Abstract Background Cold urticaria (ColdU), that is, the occurrence of wheals or
angioedema in response to cold exposure, is classified into typical and atypical forms. The …
angioedema in response to cold exposure, is classified into typical and atypical forms. The …
Phenotype and risk factors of venom-induced anaphylaxis: a case-control study of the European Anaphylaxis Registry
W Francuzik, F Ruëff, A Bauer, MB Bilò… - Journal of Allergy and …, 2021 - Elsevier
Background Venom-induced anaphylaxis (VIA) is a common, potentially life-threatening
hypersensitivity reaction associated with (1) a specific symptom profile, 2) specific cofactors …
hypersensitivity reaction associated with (1) a specific symptom profile, 2) specific cofactors …
Platelet‐activating factor acetylhydrolase is a biomarker of severe anaphylaxis in children
Background There is limited ability to predict the severity of allergic reactions in children.
Data derived predominantly from adults have implicated the platelet‐activating factor …
Data derived predominantly from adults have implicated the platelet‐activating factor …
[HTML][HTML] Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in …
F Ruëff, A Bauer, S Becker, R Brehler… - Allergologie …, 2023 - ncbi.nlm.nih.gov
Hymenoptera venom (HV) is injected into the skin during a sting by Hymenoptera such as
bees or wasps. Some components of HV are potential allergens and can cause large local …
bees or wasps. Some components of HV are potential allergens and can cause large local …
Fatal anaphylaxis: epidemiology and risk factors
I Mikhail, DR Stukus, BT Prince - Current allergy and asthma reports, 2021 - Springer
Abstract Purpose of Review To provide clinicians with an understanding of risk factors
associated with fatal anaphylaxis, and to promote individualized management plans with …
associated with fatal anaphylaxis, and to promote individualized management plans with …
Drug and venom allergy in mastocytosis
MP Giannetti… - Immunology and …, 2023 - immunology.theclinics.com
“Doctor, I cannot take any pain medications. I have mastocytosis.–Have you ever had a
reaction to aspirin, ibuprofen or other similar medications?–I have never tried since I was …
reaction to aspirin, ibuprofen or other similar medications?–I have never tried since I was …
[HTML][HTML] Mast cell diseases in practice and research: issues and perspectives raised by patients and their recommendations to the scientific community and beyond
SV Jennings, CC Finnerty, JS Hobart… - The Journal of Allergy …, 2022 - Elsevier
Background Since 2010, patients and physicians have collaborated to understand unmet
needs of patients with mast cell diseases, incorporating mastocytosis and mast cell …
needs of patients with mast cell diseases, incorporating mastocytosis and mast cell …